highly significantp<0.001
Test contrasts (0.5–32%) showed a highly significant overall increase in heterogeneity for hit trials ( Figure 3c , paired t-test, p<0.001), but such modulations were absent for probe trials.
Test contrasts (0.5–32%) showed a highly significant overall increase in heterogeneity for hit trials ( Figure 3c , paired t-test, p<0.001), but such modulations were absent for probe trials.